Editorial: Research advances of tuberculosis vaccine and its implication on COVID-19.

Gong, Wenping; Xie, Jianping; Li, Hao; Aspatwar, Ashok

Gong, Wenping; Xie, Jianping; Li, Hao; Aspatwar, Ashok.

Gong W; Tuberculosis Prevention and Control Key Laboratory/Beijing Key Laboratory of New Techniques of Tuberculosis Diagnosis and Treatment, Senior Department of Tuberculosis, The 8Medical Center of PLA General Hospital, Beijing, China.
Xie J; Institute of Modern Biopharmaceuticals, State Key Laboratory Breeding Base of Eco-Environment and Bio-Resource of the Three Gorges Area, Key Laboratory of Eco-environments in Three Gorges Reservoir Region, Ministry of Education, School of Life Sciences, Southwest University, Chongqing, China.
Li H; College of Veterinary Medicine, China Agricultural University, Beijing, China.
Aspatwar A; Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.

Front Immunol ; 14: 1147704, 2023.

Article in English | MEDLINE | ID: covidwho-2260952

Subject(s)

COVID-19; Mycobacterium tuberculosis; Tuberculosis Vaccines; Tuberculosis; Humans; COVID-19/prevention & control; Tuberculosis/prevention & control

Keywords

Mycobacterium tuberculosis; immune response; mechanism; peptide; vaccine

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Tuberculosis / Tuberculosis Vaccines / COVID-19 / Mycobacterium tuberculosis Topics: Vaccines Limits: Humans Language: English Journal: Front Immunol Year: 2023 Document Type: Article Affiliation country: Fimmu.2023.1147704

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google